Gestational Vitamin E Status and Gestational Diabetes Mellitus: A Retrospective Cohort Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
25 Mar 2023
Historique:
received: 24 01 2023
revised: 20 03 2023
accepted: 23 03 2023
medline: 14 4 2023
entrez: 13 4 2023
pubmed: 14 4 2023
Statut: epublish

Résumé

To examine the association between vitamin E (VE) status and gestational diabetes mellitus (GDM). A retrospective cohort study was conducted by using data of 52,791 women at 137 hospitals across 22 provinces of China. A fasting plasma glucose (FPG) level of ≥5.1 mmol/L between the 24th and 40th weeks of gestation was used as the criteria for the diagnosis of GDM. Mean FPG level and GDM rate were calculated within each combination of the first-trimester VE concentration categories and gestational change categories. The associations of the first-trimester VE concentrations and gestational VE change with FPG and GDM were examined by employing generalized additive models (GAMs). 7162 (13.57%) cases were diagnosed with GDM. The GDM rate was 22.44%, 11.50%, 13.41%, 12.87%, 13.17%, 13.44%, 12.64%, and 14.24% among women with the first-trimester VE concentrations of <7.2, 7.2-7.9, 8.0-9.3, 9.4-11.0, 11.1-13.2, 13.3-15.8, 15.9-17.7, and 17.8-35.9 mg/L, respectively. The GDM rate was 15.96%, 13.10%, 13.64%, and 12.87% among women with gestational VE change of <0, 0-0.19, 0.20-0.29, ≥0.30 mg/L per week, respectively. Multivariable adjusted GAM analyses found that the first-trimester VE concentration was associated with the FPG levels and GDM risk in an L-shaped pattern; the FPG levels and GDM risk decreased sharply to a threshold (around 7 mg/L), and then were keep flat. Gestational VE decreases when the first-trimester VE level was less than 11 mg/L were related to increased FPG levels and GDM risk. Both low first-trimester VE levels and subsequent gestational VE decrease were related with increased risk of GDM. The findings suggest the necessity of having VE-rich foods and appropriate VE supplementation to prevent GDM for pregnant women with low baseline VE levels.

Identifiants

pubmed: 37049439
pii: nu15071598
doi: 10.3390/nu15071598
pmc: PMC10096721
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : the National Natural Science Foundation of China
ID : 82171661
Organisme : the National Key Research and Development Program of China
ID : 2021YFC2700700

Références

Nutr Diabetes. 2022 Dec 9;12(1):49
pubmed: 36494332
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102158
pubmed: 34186370
Adv Nutr. 2021 Jun 1;12(3):1047-1048
pubmed: 33684201
J Diabetes Investig. 2019 Jan;10(1):154-162
pubmed: 29683557
J Diabetes Metab Disord. 2020 Jul 04;19(2):1787-1795
pubmed: 33553044
Lipids Health Dis. 2018 Jul 20;17(1):163
pubmed: 30025522
BMC Pregnancy Childbirth. 2018 Jun 13;18(1):225
pubmed: 29898685
Int J Mol Sci. 2021 Mar 15;22(6):
pubmed: 33803995
Int J Mol Sci. 2021 Sep 19;22(18):
pubmed: 34576285
J Matern Fetal Neonatal Med. 2019 Nov;32(22):3747-3756
pubmed: 29764249
Int J Mol Sci. 2018 Oct 26;19(11):
pubmed: 30373146
Food Sci Nutr. 2016 Mar 02;4(6):848-851
pubmed: 27826434
BJOG. 2022 Jan;129(1):82-89
pubmed: 34510695
Front Nutr. 2022 Jun 21;9:911337
pubmed: 35799589
Int J Mol Sci. 2021 Jul 12;22(14):
pubmed: 34299070
Obstet Gynecol. 2018 Feb;131(2):e49-e64
pubmed: 29370047
Pediatr Diabetes. 2008 Jun;9(3 Pt 2):57-61
pubmed: 18221434
Genes Dev. 2018 May 1;32(9-10):602-619
pubmed: 29802123
Nutrients. 2022 Apr 14;14(8):
pubmed: 35458191
J Clin Diagn Res. 2012 Dec;6(10):1624-8
pubmed: 23373014
Curr Diab Rep. 2016 Jan;16(1):7
pubmed: 26742932
Nutrients. 2021 Jun 30;13(7):
pubmed: 34209454
Lancet. 2006 Apr 8;367(9517):1145-54
pubmed: 16616557
Oxid Med Cell Longev. 2021 May 31;2021:5581570
pubmed: 34194606
Mech Ageing Dev. 2010 Apr;131(4):276-86
pubmed: 20307566
J Clin Lipidol. 2016 Mar-Apr;10(2):386-93
pubmed: 27055970

Auteurs

Huifeng Shi (H)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
National Clinical Research Centre for Obstetrics and Gynecology, Beijing 100191, China.
National Centre for Healthcare Quality Management in Obstetrics, Beijing 100191, China.

Xiaoli Gong (X)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
National Clinical Research Centre for Obstetrics and Gynecology, Beijing 100191, China.
National Centre for Healthcare Quality Management in Obstetrics, Beijing 100191, China.

Qing Sheng (Q)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
National Clinical Research Centre for Obstetrics and Gynecology, Beijing 100191, China.
National Centre for Healthcare Quality Management in Obstetrics, Beijing 100191, China.

Xiang Li (X)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
National Clinical Research Centre for Obstetrics and Gynecology, Beijing 100191, China.
National Centre for Healthcare Quality Management in Obstetrics, Beijing 100191, China.

Ying Wang (Y)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
National Clinical Research Centre for Obstetrics and Gynecology, Beijing 100191, China.
National Centre for Healthcare Quality Management in Obstetrics, Beijing 100191, China.

Tianchen Wu (T)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
National Clinical Research Centre for Obstetrics and Gynecology, Beijing 100191, China.
National Centre for Healthcare Quality Management in Obstetrics, Beijing 100191, China.

Yangyu Zhao (Y)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
National Clinical Research Centre for Obstetrics and Gynecology, Beijing 100191, China.
National Centre for Healthcare Quality Management in Obstetrics, Beijing 100191, China.

Yuan Wei (Y)

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
National Clinical Research Centre for Obstetrics and Gynecology, Beijing 100191, China.
National Centre for Healthcare Quality Management in Obstetrics, Beijing 100191, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH